SPRO Spero Therapeutics, Inc. - Common Stock
$1,21
Preço · Ago 19, 2026
Fundamentais a partir de Ago 12, 2026
Intervalo 52 Semanas
$1–$3
7% of range
Classificação do Analista
HOLD
6 analysts
Preço-Alvo
$4
+230% upside
P/E (TTM)
8.1
ROE
18.7%
Margem de Lucro Líquido
12.8%
SPRO Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$1.21
Capitalização de Mercado
$68M
P/E (TTM)
8.1
EPS (TTM)
$0.15
Receita (TTM)
$67M
Rendimento div.
—
ROE
18.7%
Dívida/Capital
—
Intervalo 52 Semanas
$1 – $3
SPRO Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$67M
2016-12-31
→
2025-12-31
EPS
$0.15
2021-12-31
→
2025-12-31
Fluxo de caixa livre
—
2017-12-31
→
2019-12-31
Margens
12.8%
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
SPRO
Mediana de Pares
P/E (TTM)
8.1
4.7
P/S (TTM)
1.0
31.0
P/B
1.2
1.8
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
SPRO
Mediana de Pares
Operating Margin (Margem Operacional)
9.4%
—
Net Profit Margin (Margem de Lucro Líquido)
12.8%
-1601.1%
ROA
9.6%
-68.1%
ROE
18.7%
-111.7%
ROIC
10.4%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
SPRO
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
7.6
4.1
Quick Ratio (Índice de Liquidez Seca)
4.5
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
SPRO
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
39.2%
—
Revenue CAGR 3Y (CAGR Receita 3A)
7.7%
—
Revenue CAGR 5Y (CAGR Receita 5A)
48.2%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
SPRO
Mediana de Pares
SPRO Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
VENDA
6 analistas
- Compra forte 0 0,0%
- Compra 0 0,0%
- Manter 3 50,0%
- Venda 1 16,7%
- Venda forte 2 33,3%
Preço-alvo de 12 meses
1 analistas · 2026-08-16
Mín
$4.00
Máx
$4.00
Alvo mediano
$4.00
+230,3%
Alvo médio
$4.00
+230,3%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
0.22%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $-0.16 | $-0.17 | 0.01% |
| 31 de Março de 2026 | $-0.13 | $-0.18 | 0.05% |
| 31 de Dezembro de 2025 | $0.53 | $-0.20 | 0.73% |
| 30 de Setembro de 2025 | $-0.13 | $-0.26 | 0.12% |
| 30 de Junho de 2025 | $-0.03 | $-0.39 | 0.36% |
| 31 de Março de 2025 | $-0.25 | $-0.56 | 0.31% |
| 31 de Dezembro de 2024 | $-0.38 | $-0.32 | -0.06% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| SPRO | $131M | 15.5 | 39.2% | 12.8% | 18.7% | — |
| FRMM | — | — | — | -6881.3% | -368.1% | — |
| DWTX | $124M | -0.6 | 123.6% | — | -83.8% | — |
| GOSS | $724M | -4.1 | -57.7% | -351.5% | 201.8% | — |
| CTOR | $170M | -6.0 | — | — | -61.5% | — |
| IBIO | $15M | -0.4 | 77.8% | -4594.2% | -101.5% | — |
| CRDF | $192M | -4.1 | -13.2% | -7732.0% | -88.2% | — |
| XBIT | — | -1.6 | — | — | — | — |
| NMAD | — | — | — | — | — | — |
| MNOV | $64M | -5.5 | — | -2928.8% | -27.1% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 15
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $67M | $48M | $104M | $54M | $18M | $9M | $18M | $4M | $2M | $335.0K | |
| R&D Expense | $38M | $97M | $51M | $48M | $65M | $67M | $66M | $34M | $33M | $26M | |
| SG&A Expense | $21M | $24M | $26M | $36M | $42M | $21M | $16M | $13M | $11M | $7M | |
| Operating Expenses | $60M | $121M | $82M | $96M | $106M | $88M | $81M | $47M | $44M | $34M | |
| Operating Income | $6M | $-73M | $21M | $-42M | $-88M | $-79M | $-63M | $-43M | $-42M | $-33M | |
| Interest Income | $3M | $5M | $4M | $1M | $346.0K | $401.0K | $1M | $1M | · | · | |
| Other Non-op | $7.0K | $60.0K | $-14.0K | $-55.0K | $-395.0K | $432.0K | $740.0K | $43.0K | $2M | $580.0K | |
| Pretax Income | $9M | $-69M | $25M | $-46M | $-90M | $-78M | $-61M | $-42M | $-40M | $-33M | |
| Income Tax | $261.0K | $0 | $3M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $9M | $-69M | $23M | $-46M | $-90M | $-78M | $-61M | $-42M | $-39M | $-25M | |
| EPS (Basic) | $0.15 | $-1.27 | $0.43 | $-1.23 | $-2.91 | · | · | · | · | · | |
| EPS (Diluted) | $0.15 | $-1.27 | $0.43 | $-1.23 | $-2.91 | · | · | · | · | · | |
| Shares (Basic) | 56,020,363 | 54,037,917 | 52,703,467 | 37,585,075 | 30,895,756 | · | · | · | · | · | |
| Shares (Diluted) | 59,039,225 | 54,037,917 | 52,989,030 | 37,585,075 | 30,895,756 | · | · | · | · | · | |
| EBITDA | $6M | $-73M | $22M | $-41M | $-87M | · | $-62M | $-42M | $-41M | · |
Balanço Patrimonial 21
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $40M | $53M | $76M | $109M | $113M | $85M | $30M | $34M | $87M | $10M | |
| Short-term Investments | · | · | · | $0 | $34M | $42M | $52M | $81M | · | · | |
| Prepaid Expense | $2M | $2M | $4M | $3M | $9M | $6M | $5M | $7M | $2M | $1M | |
| Other Current Assets | $28.0K | · | · | · | · | · | · | · | · | · | |
| Current Assets | $67M | $107M | $131M | $114M | $158M | $139M | $95M | $124M | $92M | $12M | |
| PP&E (Net) | · | $0 | $2.0K | $368.0K | $1M | $2M | $2M | $3M | $1M | $2M | |
| PP&E (Gross) | · | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $2M | $2M | |
| Accum. Depreciation | · | $4M | $4M | $3M | $3M | $2M | $2M | $827.0K | $643.0K | $290.0K | |
| Other Non-current Assets | $153.0K | $153.0K | $435.0K | $6M | $6M | $5M | $4M | $2M | · | · | |
| Total Assets | $69M | $111M | $182M | $125M | $171M | $153M | $106M | $129M | $93M | $14M | |
| Accounts Payable | $693.0K | $7M | $1M | $617.0K | $1M | $1M | $4M | $4M | $3M | $1M | |
| Current Liabilities | $9M | $49M | $37M | $22M | $19M | $14M | $27M | $12M | $8M | $7M | |
| Capital Leases | $939.0K | $3M | $4M | $5M | $6M | $7M | $5M | · | · | · | |
| Total Liabilities | $10M | $64M | $75M | $49M | $83M | $21M | $32M | $13M | $9M | $7M | |
| Common Stock | $56.0K | $55.0K | $53.0K | $52.0K | $32.0K | $29.0K | $19.0K | $17.0K | $14.0K | $0 | |
| Paid-in Capital | · | · | · | · | · | · | · | $254M | $181M | $0 | |
| Retained Earnings | $-451M | $-460M | $-391M | $-414M | $-367M | $-278M | $-199M | $-139M | $-97M | $-45M | |
| AOCI | · | · | $0 | $0 | $-2.0K | $-7.0K | $16.0K | $-28.0K | · | · | |
| Stockholders' Equity | $59M | $46M | $107M | $76M | $88M | $132M | $75M | $116M | $85M | $-45M | |
| Liabilities + Equity | $69M | $111M | $182M | $125M | $171M | $153M | $106M | $129M | $93M | $14M | |
| Shares Outstanding | 56,414,657 | 54,593,527 | 52,999,680 | 52,456,195 | 32,393,738 | 29,260,247 | 19,190,695 | 17,205,962 | 14,369,182 | 0 |
Fluxo de Caixa 13
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $0 | $2.0K | $367.0K | $869.0K | $646.0K | $761.0K | $750.0K | $409.0K | $363.0K | $279.0K | |
| Stock-based Comp | $4M | $8M | $8M | $9M | $9M | $5M | $4M | $3M | $1M | $180.0K | |
| Deferred Tax | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Restructuring | $258.0K | $877.0K | $0 | $12M | $0 | · | · | · | · | · | |
| Other Non-cash | $-26M | $37M | $-64M | $29M | $15M | · | $6M | $-1M | $-2M | · | |
| Operating Cash Flow | $-13M | $-23M | $-33M | $-8M | $-64M | $-86M | $-50M | $-40M | $-39M | $-29M | |
| CapEx | · | · | · | · | · | $157.0K | $314.0K | $2M | $27.0K | $830.0K | |
| Investing Cash Flow | · | · | $0 | $34M | $8M | $10M | $30M | $-83M | $-27.0K | $-830.0K | |
| Stock Issued | · | $0 | $221.0K | · | $8M | $13M | $16M | · | · | · | |
| Net Stock Activity | · | $0 | · | · | $8M | · | $16M | · | · | · | |
| Financing Cash Flow | · | $0 | $221.0K | $-30M | $84M | $131M | $16M | $70M | $116M | $34M | |
| Net Change in Cash | $-13M | $-23M | $-33M | $-3M | $27M | $55M | $-4M | $-53M | $77M | $5M | |
| Free Cash Flow | · | · | · | · | · | · | $-50M | $-42M | $-39M | · |
Lucratividade 7
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 9.4% | -152.9% | 20.7% | -78.9% | -481.9% | · | -348.4% | -1079.3% | · | · | |
| Net Margin | 12.8% | -142.9% | 22.0% | -86.7% | -491.9% | · | -335.6% | -1050.5% | · | · | |
| Pretax Margin | 13.2% | -142.9% | 24.5% | -86.7% | -491.7% | · | -335.7% | -1050.5% | · | · | |
| EBITDA Margin | 9.4% | -152.9% | 21.1% | -77.2% | -478.3% | · | -344.2% | -1069.0% | · | · | |
| ROA | 9.6% | -46.8% | 14.8% | -31.4% | -55.3% | · | -51.8% | -37.5% | -72.2% | · | |
| ROE | 18.7% | -122.8% | 28.4% | -85.6% | -89.7% | · | -64.1% | -41.6% | -197.9% | · | |
| ROIC | 10.4% | -159.1% | 18.0% | -55.6% | -99.6% | · | -84.8% | -37.1% | -49.3% | · |
Liquidez e Solvência 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.6 | 2.2 | 3.5 | 5.2 | 8.5 | · | 3.6 | 10.1 | 11.3 | · | |
| Quick Ratio | 4.5 | 1.1 | 2.1 | 5.0 | 7.8 | · | 3.1 | 9.4 | 10.7 | · |
Eficiência 1
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.3 | 0.7 | 0.4 | 0.1 | · | 0.2 | 0.0 | · | · |
Taxas de Crescimento 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 39.2% | -53.8% | 94.0% | 193.1% | 95.7% | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.7% | 38.0% | 123.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 48.2% | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 10
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $67M | $48M | $104M | $54M | $18M | $9M | $18M | $4M | $2M | · | |
| Net Income TTM | $9M | $-69M | $23M | $-46M | $-90M | $-78M | $-61M | $-42M | $-39M | · | |
| Market Cap | $131M | $56M | $78M | $91M | $519M | · | $185M | $106M | $169M | · | |
| P/E | 15.5 | -0.8 | 3.4 | -1.4 | -5.5 | · | · | · | · | · | |
| P/S | 2.0 | 1.2 | 0.8 | 1.7 | 28.4 | · | 10.2 | 26.7 | 85.3 | · | |
| P/B | 2.2 | 1.2 | 0.7 | 1.2 | 5.9 | · | 2.5 | 0.9 | 2.0 | · | |
| P / Tangible Book | 2.2 | 1.2 | 0.7 | 1.2 | 5.9 | 4.3 | · | · | · | · | |
| P / Cash Flow | -10.4 | -2.4 | -2.4 | -11.7 | -8.1 | · | -3.7 | -2.7 | -4.3 | · | |
| P / FCF | · | · | · | · | · | · | -3.7 | -2.5 | -4.3 | · | |
| Earnings Yield | 6.4% | -123.3% | 29.2% | -71.1% | -18.2% | · | · | · | · | · |
Demonstração de Resultados 14
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $258.0K | $41M | $5M | $14M | $6M | $15M | $13M | $10M | $9M | $74M | $25M | $3M | $2M | $47M | $2M | |
| R&D Expense | $3M | $3M | $6M | $9M | $11M | $14M | $29M | $27M | $24M | $17M | $17M | $16M | $10M | $9M | $15M | $7M | |
| SG&A Expense | $6M | $5M | $4M | $4M | $6M | $7M | $7M | $5M | $6M | $6M | $6M | $6M | $6M | $7M | $6M | $7M | |
| Operating Expenses | $10M | $8M | $10M | $13M | $17M | $21M | $37M | $32M | $29M | $23M | $23M | $27M | $16M | $16M | $22M | $14M | |
| Operating Income | $-10M | $-8M | $31M | $-8M | $-2M | $-15M | $-22M | $-19M | $-19M | $-14M | $51M | $-2M | $-13M | $-14M | $26M | $-12M | |
| Interest Income | $377.0K | $336.0K | $376.0K | $532.0K | $740.0K | $864.0K | $1M | $1M | $1M | $1M | $1M | $950.0K | $982.0K | $963.0K | $715.0K | $208.0K | |
| Other Non-op | $-3.0K | $-1.0K | $0 | $2.0K | $4.0K | $1.0K | $99.0K | $-26.0K | $1.0K | $-14.0K | $4.0K | $-10.0K | $-6.0K | $-2.0K | $-9.0K | $-23.0K | |
| Income Tax | · | · | $261.0K | $0 | · | · | $-290.0K | $290.0K | · | · | $387.0K | $2M | · | · | $0 | $0 | |
| Net Income | $-10M | $-7M | $32M | $-7M | $-2M | $-14M | $-21M | $-17M | $-18M | $-13M | $51M | $-3M | $-12M | $-13M | $27M | $-12M | |
| EPS (Basic) | $-0.16 | $-0.13 | $0.56 | $-0.13 | $-0.03 | $-0.25 | $-0.38 | $-0.32 | $-0.33 | $-0.24 | $0.97 | $-0.06 | $-0.23 | $-0.25 | $0.98 | $-0.33 | |
| EPS (Diluted) | $-0.16 | $-0.13 | $0.56 | $-0.13 | $-0.03 | $-0.25 | $-0.38 | $-0.32 | $-0.33 | $-0.24 | $0.97 | $-0.06 | $-0.23 | $-0.25 | $0.98 | $-0.33 | |
| Shares (Basic) | 57,968,608 | 57,281,570 | -111,663,436 | 56,280,844 | 56,026,767 | 55,376,188 | -107,568,748 | 54,124,862 | 53,957,766 | 53,524,037 | -105,105,644 | 52,710,280 | 52,571,813 | 52,527,018 | -63,881,523 | 35,882,076 | |
| Shares (Diluted) | 57,968,608 | 57,281,570 | -108,644,574 | 56,280,844 | 56,026,767 | 55,376,188 | -107,568,748 | 54,124,862 | 53,957,766 | 53,524,037 | -104,820,081 | 52,710,280 | 52,571,813 | 52,527,018 | -63,881,523 | 35,882,076 | |
| EBITDA | $-10M | $-8M | · | $-8M | $-2M | $-15M | · | $-19M | $-19M | $-14M | · | $-2M | $-13M | $-14M | · | $-12M |
Balanço Patrimonial 20
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $51M | $56M | $40M | $49M | $31M | $49M | $53M | $76M | $64M | $82M | $76M | $94M | $78M | $96M | $109M | $50M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Prepaid Expense | $785.0K | $1M | $2M | $1M | $1M | $2M | $2M | $2M | $3M | $4M | $4M | $5M | $9M | $4M | $3M | $1M | |
| Other Current Assets | $25.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $52M | $58M | $67M | $52M | $59M | $75M | $107M | $132M | $122M | $140M | $131M | $102M | $88M | $102M | $114M | $53M | |
| PP&E (Net) | · | · | · | · | · | · | · | $0 | $0 | $2.0K | $2.0K | $41.0K | $148.0K | $256.0K | $368.0K | $494.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | $4M | · | · | · | $4M | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | $4M | · | · | · | $3M | · | |
| Other Non-current Assets | $153.0K | $153.0K | $153.0K | $153.0K | $153.0K | $153.0K | $153.0K | $153.0K | $434.0K | $434.0K | $435.0K | $434.0K | $6M | $6M | $6M | $6M | |
| Total Assets | $53M | $59M | $69M | $54M | $62M | $78M | $111M | $135M | $150M | $168M | $182M | $107M | $99M | $113M | $125M | $64M | |
| Accounts Payable | $155.0K | $217.0K | $693.0K | $1M | $780.0K | $2M | $7M | $6M | $3M | $3M | $1M | $1M | $1M | $583.0K | $617.0K | $3M | |
| Current Liabilities | $8M | $5M | $9M | $14M | $15M | $29M | $49M | $49M | $46M | $42M | $37M | $25M | $17M | $23M | $22M | $16M | |
| Capital Leases | $43.0K | $507.0K | $939.0K | $1M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | |
| Total Liabilities | $9M | $6M | $10M | $28M | $29M | $44M | $64M | $70M | $69M | $71M | $75M | $53M | $44M | $48M | $49M | $32M | |
| Common Stock | $58.0K | $58.0K | $56.0K | $56.0K | $56.0K | $56.0K | $55.0K | $54.0K | $54.0K | $54.0K | $53.0K | $53.0K | $53.0K | $53.0K | $52.0K | $43.0K | |
| Retained Earnings | $-468M | $-458M | $-451M | $-483M | $-475M | $-474M | $-460M | $-439M | $-422M | $-404M | $-391M | $-442M | $-439M | $-427M | $-414M | $-441M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Stockholders' Equity | $44M | $53M | $59M | $26M | $33M | $34M | $46M | $66M | $80M | $96M | $107M | $54M | $55M | $65M | $76M | $32M | |
| Liabilities + Equity | $53M | $59M | $69M | $54M | $62M | $78M | $111M | $135M | $150M | $168M | $182M | $107M | $99M | $113M | $125M | $64M | |
| Shares Outstanding | 58,146,910 | 57,891,493 | 56,414,657 | 56,311,795 | 56,187,308 | 55,900,641 | 54,593,527 | 54,314,415 | 54,009,139 | 53,869,139 | 52,999,680 | 52,999,317 | 52,571,813 | 52,571,813 | 52,456,195 | 42,856,623 |
Fluxo de Caixa 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $0 | $0 | · | · | $0 | $0 | $2.0K | $0 | $38.0K | $108.0K | $108.0K | $113.0K | $129.0K | $257.0K | |
| Stock-based Comp | $822.0K | $1M | $1M | $1M | $714.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Restructuring | $0 | $0 | $0 | $0 | $83.0K | $175.0K | $877.0K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-67.0K | $-152.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $17M | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-5M | $16M | $-8M | $17M | $-18M | $-4M | $-23M | $13M | $-19M | $6M | $-17M | $16M | $-19M | $-13M | $44M | $-957.0K | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $-129.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $1.0K | $220.0K | $0 | $0 | · | $6M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | · | · | · | · | · | · | · | · | · | · | $1.0K | $220.0K | $0 | $0 | $14M | $6M | |
| Net Change in Cash | $-5M | $16M | $-8M | $17M | $-18M | $-4M | $-23M | $13M | $-19M | $6M | $-17M | $16M | $-19M | $-13M | $59M | $5M |
Lucratividade 5
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -2921.7% | · | -145.5% | -17.2% | -250.8% | · | -138.0% | -186.9% | -150.9% | · | -7.6% | -474.6% | -687.6% | · | -589.9% | |
| Net Margin | · | -2791.9% | · | -135.7% | -12.0% | -236.1% | · | -127.3% | -175.5% | -137.1% | · | -12.6% | -438.1% | -642.8% | · | -583.2% | |
| EBITDA Margin | · | -2921.7% | · | -145.5% | -17.2% | -250.8% | · | -138.0% | -186.9% | -150.9% | · | -7.6% | -474.6% | -682.2% | · | -589.9% | |
| ROA | -16.6% | -10.5% | · | -7.8% | -1.6% | -11.3% | · | -14.2% | -14.4% | -9.1% | · | -3.7% | -14.6% | -10.3% | · | -11.2% | |
| ROE | -24.8% | -16.6% | · | -16.1% | -3.0% | -21.3% | · | -28.8% | -26.5% | -15.8% | · | -7.4% | -26.2% | -20.9% | · | -16.2% |
Liquidez e Solvência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 10.5 | · | 3.8 | 4.0 | 2.6 | · | 2.7 | 2.7 | 3.4 | · | 4.0 | 5.1 | 4.4 | · | 3.3 | |
| Quick Ratio | 6.0 | 10.2 | · | 3.6 | 2.1 | 1.7 | · | 1.6 | 1.4 | 2.0 | · | 3.7 | 4.5 | 4.2 | · | 3.1 |
Eficiência 1
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.3 | 0.0 | 0.0 | · | 0.0 |
Avaliação (TTM) 9
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20M | $26M | · | $39M | $44M | $39M | · | $58M | $48M | $40M | · | $32M | $9M | $8M | · | $9M | |
| Net Income TTM | $-26M | $-30M | · | $-40M | $-51M | $-62M | · | $-51M | $-46M | $-41M | · | $-40M | $-66M | $-86M | · | $-96M | |
| Market Cap | $129M | $135M | · | $106M | $163M | $40M | · | $73M | $70M | $93M | · | $64M | $76M | $76M | · | $86M | |
| P/E | -4.9 | -4.3 | · | -2.6 | -3.1 | -0.6 | · | -1.4 | -1.5 | -2.2 | · | -1.4 | -0.9 | -0.6 | · | -0.7 | |
| P/S | 6.5 | 5.3 | · | 2.7 | 3.7 | 1.0 | · | 1.2 | 1.5 | 2.3 | · | 2.0 | 8.7 | 9.4 | · | 9.4 | |
| P/B | 2.9 | 2.6 | · | 4.0 | 5.0 | 1.2 | · | 1.1 | 0.9 | 1.0 | · | 1.2 | 1.4 | 1.2 | · | 2.6 | |
| P / Tangible Book | 2.9 | 2.6 | · | 4.0 | 5.0 | 1.2 | · | 1.1 | 0.9 | 1.0 | · | 1.2 | 1.4 | 1.2 | · | 2.6 | |
| P / Cash Flow | · | 8.5 | · | · | · | -10.1 | · | · | · | 15.6 | · | · | · | -5.9 | · | · | |
| Earnings Yield | -20.4% | -23.1% | · | -38.8% | -32.1% | -158.3% | · | -70.9% | -66.1% | -45.4% | · | -71.9% | -115.9% | -169.7% | · | -145.5% |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $67M | $48M | $104M | $54M | $18M |
| Margem Operacional % | 9.4% | -152.9% | 20.7% | -78.9% | -481.9% |
| Lucro líquido | $9M | $-69M | $23M | $-46M | $-90M |
| EPS Diluído | $0.15 | $-1.27 | $0.43 | $-1.23 | $-2.91 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 7.6 | 2.2 | 3.5 | 5.2 | 8.5 |
| Índice de Liquidez Seca | 4.5 | 1.1 | 2.1 | 5.0 | 7.8 |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 69 declarantes · $49.2M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 27 (+16 vs trimestre anterior) | 11 (-1 vs trimestre anterior) | 14 (+3 vs trimestre anterior) | 8 (-3 vs trimestre anterior) | +275K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| GSK plc | $20.311.239 | 9.190.606 | 41,27% | Ações |
| Pfizer Inc | $5.338.906 | 2.362.348 | 10,85% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.500.059 | 2.036.226 | 9,14% | Ações |
| VANGUARD GROUP INC | $4.179.789 | 1.793.901 | 8,49% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $2.094.868 | 947.904 | 4,26% | Ações |
| Alphabet Inc. | $1.966.854 | 889.979 | 4,00% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.678.031 | 759.290 | 3,41% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $1.026.816 | 464.370 | 2,09% | Ações |
| TWO SIGMA INVESTMENTS, LP | $846.019 | 382.814 | 1,72% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $735.864 | 332.970 | 1,50% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $635.702 | 287.648 | 1,29% | Ações |
| GOLDMAN SACHS GROUP INC | $567.937 | 256.985 | 1,15% | Ações |
| TWO SIGMA ADVISERS, LP | $504.678 | 216.600 | 1,03% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $484.794 | 219.364 | 0,99% | Ações |
| STATE STREET CORP | $474.600 | 214.751 | 0,96% | Ações |
| JANE STREET GROUP, LLC | $349.394 | 158.097 | 0,71% | Ações |
| UBS Group AG | $308.693 | 139.680 | 0,63% | Ações |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $253.708 | 114.800 | 0,52% | Ações |
| NORTHERN TRUST CORP | $239.286 | 108.274 | 0,49% | Ações |
| Point72 Asset Management, L.P. | $230.673 | 104.377 | 0,47% | Ações |
| Ionic Capital Management LLC | $226.963 | 102.698 | 0,46% | Ações |
| Federation des caisses Desjardins du Quebec | $202.180 | 91.900 | 0,41% | Ações |
| Shay Capital LLC | $159.984 | 72.391 | 0,33% | Ações |
| CITADEL ADVISORS LLC | $144.976 | 65.600 | 0,29% | Opção de venda |
| Invesco Ltd. | $141.981 | 64.245 | 0,29% | Ações |
| SIMPLEX TRADING, LLC | $135.499 | 61.312 | 0,28% | Ações |
| Verdad Advisers, LP | $113.450 | 51.335 | 0,23% | Ações |
| XTX Topco Ltd | $111.685 | 50.536 | 0,23% | Ações |
| JANE STREET GROUP, LLC | $104.091 | 47.100 | 0,21% | Opção de compra |
| AMERICAN CENTURY COMPANIES INC | $81.352 | 36.811 | 0,17% | Ações |
| Cubist Systematic Strategies, LLC | $76.789 | 40.845 | 0,16% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $76.466 | 34.600 | 0,16% | Opção de venda |
| AXXCESS WEALTH MANAGEMENT, LLC | $71.931 | 32.548 | 0,15% | Ações |
| Capital Asset Advisory Services LLC | $71.931 | 32.548 | 0,15% | Ações |
| Three Seasons Wealth, LLC | $66.300 | 30.000 | 0,13% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $63.129 | 28.565 | 0,13% | Ações |
| JANE STREET GROUP, LLC | $59.228 | 26.800 | 0,12% | Opção de venda |
| Vanguard Global Advisers, LLC | $56.236 | 25.446 | 0,11% | Ações |
| Global Retirement Partners, LLC | $55.250 | 25.000 | 0,11% | Ações |
| OPPENHEIMER & CO INC | $50.499 | 22.850 | 0,10% | Ações |
| MILLENNIUM MANAGEMENT LLC | $42.649 | 19.298 | 0,09% | Ações |
| Assenagon Asset Management S.A. | $41.186 | 18.636 | 0,08% | Ações |
| DLK Investment Management, LLC | $40.762 | 31.355 | 0,08% | Ações |
| Susquehanna Portfolio Strategies, LLC | $38.958 | 17.628 | 0,08% | Ações |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | $35.570 | 16.095 | 0,07% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $30.277 | 13.700 | 0,06% | Opção de compra |
| Qube Research & Technologies Ltd | $30.153 | 13.644 | 0,06% | Ações |
| GROUP ONE TRADING LLC | $24.020 | 10.869 | 0,05% | Ações |
| TWO SIGMA SECURITIES, LLC | $23.373 | 10.576 | 0,05% | Ações |
| PRUDENTIAL FINANCIAL INC | $22.984 | 10.400 | 0,05% | Ações |
| BlackRock, Inc. | $22.476 | 10.170 | 0,05% | Ações |
| CITIGROUP INC | $21.271 | 9.625 | 0,04% | Ações |
| JONES FINANCIAL COMPANIES LLLP | $17.352 | 7.678 | 0,04% | Ações |
| Integrated Wealth Concepts LLC | $13.260 | 6.000 | 0,03% | Ações |
| ROYAL BANK OF CANADA | $4.000 | 2.014 | 0,01% | Ações |
| WR Wealth Planners, LLC | $2.678 | 2.600 | 0,01% | Ações |
| RAYMOND JAMES FINANCIAL INC | $2.210 | 1.000 | 0,00% | Ações |
| FMR LLC | $663 | 300 | 0,00% | Ações |
| OSAIC HOLDINGS, INC. | $640 | 290 | 0,00% | Ações |
| GSA CAPITAL PARTNERS LLP | $632 | 285.906 | 0,00% | Ações |
| JPMORGAN CHASE & CO | $533 | 236 | 0,00% | Ações |
| WELLS FARGO & COMPANY/MN | $442 | 200 | 0,00% | Ações |
| Rialto Wealth Management, LLC | $381 | 172 | 0,00% | Ações |
| US BANCORP \DE\ | $334 | 151 | 0,00% | Ações |
| MORGAN STANLEY | $29 | 13 | 0,00% | Ações |
| SBI Securities Co., Ltd. | $29 | 13 | 0,00% | Ações |
| SG Americas Securities, LLC | $25 | 11.268 | 0,00% | Ações |
| Farther Finance Advisors, LLC | $22 | 10 | 0,00% | Ações |
| FNY Investment Advisers, LLC | $18 | 8.300 | 0,00% | Ações |
Executivos da empresa 22 insiders · 9 diretores · 12 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Esther Rajavelu | Chief Executive Officer, Chief Financial Officer and Chief Business Officer | 4 de Maio de 2026 S | 986.851 | 0 | 5 | $-406.848 |
| Sath Shukla | CEO & President | 5 de Fevereiro de 2025 S | 1.736.883 | 0 | 0 | $0 |
| Joel Sendek | Chief Financial Officer | 2 de Janeiro de 2019 A | 15.181 | 0 | 0 | $0 |
| Timothy Keutzer | Chief Operating Officer | 6 de Fevereiro de 2026 S | 742.506 | 0 | 5 | $-148.532 |
| Cristina Larkin | Chief Operating Officer | 1 de Fevereiro de 2022 A | 63.581 | 0 | 0 | $0 |
| Kamal Hamed | Chief Medical Officer | 2 de Fevereiro de 2024 S | 788.117 | 0 | 0 | $0 |
| Tamara L Joseph | Chief Legal Officer | 2 de Fevereiro de 2024 S | 531.615 | 0 | 0 | $0 |
| David A. Melnick | Chief Medical Officer | 1 de Fevereiro de 2022 A | 62.081 | 0 | 0 | $0 |
| Thomas R Parr JR | Chief Scientific Officer | 2 de Janeiro de 2019 A | — | 0 | 0 | $0 |
| Kathleen Tregoning | Conselheiro | 23 de Junho de 2026 A | 85.000 | 0 | 0 | $0 |
| Cynthia Smith | Conselheiro | 23 de Junho de 2026 A | 85.000 | 0 | 0 | $0 |
| Scott Thomas Jackson | Conselheiro | 23 de Junho de 2026 A | 85.000 | 0 | 0 | $0 |
| Patrick V.J.J. Vink | Conselheiro | 23 de Junho de 2026 A | 85.000 | 0 | 0 | $0 |
| Milind Deshpande | Conselheiro | 23 de Junho de 2026 A | 101.454 | 0 | 0 | $0 |
| John C Pottage Jr | Conselheiro | 23 de Junho de 2026 A | 85.000 | 0 | 0 | $0 |
| Frank E Thomas | Conselheiro | 23 de Junho de 2026 A | 85.000 | 0 | 0 | $0 |
| Ankit Mahadevia | Conselheiro | 28 de Agosto de 2025 S | 703.294 | 0 | 1 | $-12.947 |
| FORMELA JEAN FRANCOIS | Conselheiro | 17 de Agosto de 2021 A | 2.408.128 | 0 | 0 | $0 |
| Casper Breum | Conselheiro | 5 de Junho de 2018 A | 1.091.774 | 0 | 0 | $0 |
| David P Southwell | Conselheiro | 5 de Junho de 2018 A | — | 0 | 0 | $0 |
| Vikas Goyal | Conselheiro | 6 de Novembro de 2017 C | 1.854.006 | 0 | 0 | $0 |
| Debra Zack | — | 3 de Agosto de 2026 A | 162.311 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 1 participação
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| ATLAS VENTURE FUND X, L.P., ATLAS VENTURE ASSOCIATES X, L.P., Atlas Venture Associates X, LLC ×2 declarações | 16 de Fevereiro de 2021 | — | Declaração inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 8 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 22.770 NS | 31 de Maio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 15.934 NS | 30 de Abril de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 4.874 NS | 30 de Abril de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 de Julho de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 de Julho de 2026 | Diário |
| IWC · iShares Trust | — | — | 18 de Agosto de 2026 | Diário |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 13 de Julho de 2026 | Diário |
| QQQS · Invesco Exchange-Traded Fund Trust … | — | — | 20 de Julho de 2026 | Diário |